エピソード
-
In this episode of AbbottTalks, Kartik Sundareswaran, PhD, divisional VP, global clinical and regulatory affairs, Abbott Heart Failure, discusses Abbott’s pioneering work in heart failure care, focusing on technologies that improve outcomes and empower earlier interventions.
Sundareswaran’s path to MedTech began with a shift from computer engineering to biomedical research, where his early work studying blood flow patterns in children with congenital heart disease sparked a passion for solving cardiovascular challenges. This passion led him to roles at Thoratec, St. Jude Medical, and ultimately Abbott, where he has spent years advancing heart failure care.
The conversation highlights Abbott’s CardioMEMS™ Heart Failure System, a device enabling remote pulmonary artery pressure monitoring to reduce hospitalizations, and the HeartMate 3 LVAD, which provides life-extending support for patients with advanced heart failure. Sundareswaran also discusses the new TEAM-HF clinical trial, which combines CardioMEMS and HeartMate 3 to identify patients earlier and deliver timely, effective interventions.
This conversation comes to you courtesy of our episode sponsor, Tecan Group Ltd. To learn more about how Tecan works with medical device companies, visit: https://partnering.tecan.com/
Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode. -
In this episode of DeviceTalks Weekly, we’ll hear how Perimeter Medical Imaging AI hopes to help surgeons get a clearer picture of whether they removed all cancerous tissue in a surgical procedure. CEO Adrian Mendes explains why 20% of patients who have undergone a lumpectomy must undergo a second operation to remove cancerous tissue that had been missed. Perimeter recently released the positive results from its pivotal study showing it more effectively addressed residual cancer at the surgical margin during surgery as compared to current standard methods. The company is planning to file a PMA with the FDA. Mendes also talks with Host Tom Salemi about his path from the technology industry into running an OCT and AI company targeting oncology.
Perimeter Medical Imaging AI sponsored this episode of the DeviceTalks Weekly Podcast. For more information go to https://perimetermed.com/
MedTech CEO Paul Grand joins Tom and MassDevice Editor Chris Newmarker for this week’s Newmarker’s Newsmakers - Capstan Medical, Cala Health, Anteris Technologies, MedTech M&A and top stories.
Thanks for listening to this episode of the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. -
エピソードを見逃しましたか？
-
In this episode of Structural Heart Talks, Todd Brinton, MD, Chief Scientific Officer & CVP, Advanced Technology at Edwards Lifesciences, discusses Edwards’ vision of future innovative technologies that elevate patient care and expand the possibilities of structural heart therapies. Brinton reflects on his journey from biomedical engineering to pioneering roles in MedTech, including his work at Shockwave Medical, and shares how these experiences shaped his mission to create impactful technologies for patients worldwide.
The conversation dives deep into Edwards’ evolving focus on structural heart failure and non-valvular structural heart therapies, emphasizing investigational programs that challenge traditional approaches and push the boundaries of interventional cardiology. Brinton highlights how Edwards fosters a mission-driven culture of collaboration, uniting engineering, clinical expertise, and market insights to tackle some of the most complex challenges in cardiac care.
The episode also underscores the transformative role of mentorship in Brinton’s career and his commitment to paying it forward by empowering others in the MedTech space. Drawing on personal stories, Brinton illustrates how embracing failure and leveraging diverse perspectives have driven innovation at Edwards, paving the way for new therapies that can improve care for patients globally.
* Please note that this episode was recorded before the sale of Edwards’ Critical Care business unit to BD, which closed on Sept 3, 2024.
Thank you to Integer for sponsoring this episode of Structural Heart Talks. To learn more about how Integer supports medical device companies, visit www.Integer.net.
Thank you for listening to the Structural Heart Talks podcast. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks or the Structural Heart Talks on YouTube Podcasts to ensure you never miss an episode. -
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi unpacks the career of Tesh Elavia, vice president of research and development at BD’s surgery division. Elavia’s parents strongly encouraged him to leave his home in India to study in the states. Listeners will hear how he built that uncertain start into a stellar MedTech career.
This episode is sponsored by FPT. Learn more about the company in the podcast or visit FPTsoftware.com
MassDevice Editor Chris Newmarker kicks this off with the Newmarker’s Newsmakers - Edwards Lifesciences, GE Healthcare, Movano Health, Boston Scientific and layoffs in the MedTech Industry.
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. -
In this episode of Neuro Innovation Talks, Host John Murray interviews Professor Jacques Moret, MD, Professor and Consultant Interventional Neuroradiology and Honorary Chairman, NEURI center, Bicetre University Hospital, a pioneer in neurovascular intervention, as he reflects on the early challenges and groundbreaking innovations that shaped the field.
Dr. Moret recounts the origins of balloon remodeling for brain aneurysm treatment, detailing the iterative process of developing this transformative technique and the critical role of collaboration with industry leaders. He highlights the technological and ethical considerations that informed his work, emphasizing the balance between innovation and patient safety.
The conversation delves into his philosophy of mentorship, the significance of anatomical knowledge in neurointervention, and the importance of maintaining humanity in patient care. Dr. Moret also discusses the future of neurovascular treatment, advocating for MRI-compatible devices and real-time functional imaging to enhance procedural outcomes.
Thank you to Confluent Medical Technologies for sponsoring this episode of Neuro Innovation Talks. To learn more about how Confluent Medical supports medical device companies, visit: www.confluentmedical.com.
Special thanks to the following, the Neuro Innovation Talks podcast series would not be possible without their support: Joanna Colangelo, Mark Dickinson, Whitney Garrett, Tracy Murray, SYK, Dr. Christophe Cognard, Dr. Laurent Spelle, and Dr. Vitor Pereira
Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode.
Thank you for supporting the Neuro Innovation Talks podcast! -
Where does Iman Jeddi see Intuitive’s da Vinci 5 - and robotics - fit into the future of surgery?
In this episode of IntuitiveTalks, Iman Jeddi, PhD, senior vice president and general manager of the company’s multi port platform, shares a vision for the future of surgery where robotic systems elevate the performance of surgeons and deliver greater care equity.
Jeddi’s career started in biomedical engineering, taking her through several start-ups and ultimately, Abbott. Her lifelong career goal to create technology that improved care for the many led her to join Intuitive Surgical in 2013.
Jeddi has held multiple leadership roles in engineering, operations, and quality. Prior to taking her current post, Jeddi was general manager of the single-port platform, da Vinci SP, so she brings a uniquely comprehensive perspective to the company’s surgical robotic portfolio.
The interview begins and ends with a personal story illustrating her belief in building medical devices and tools that can deliver better care for as many patients as possible.
Thank you to Aptyx for sponsoring this episode of IntuitiveTalks! Please visit www.aptyx.com to learn more about how Aptyx can help you manufacture your competitive edge.
Thank you for listening to the IntuitiveTalks Podcast.
Subscribe to this podcast on every major podcast platform. -
In this episode of DeviceTalks Weekly, Host Tom Salemi interviews Kit Yee Au-Yeung, general manager of AQMed at SandBoxAQ, an Alphabet spinout using AI and sensors to develop new tools in several industries.
Sandbox’s medical group is using these new technologies to develop advanced AI-powered magnetocardiography (MCG) technology to improve cardiac diagnostics.
MassDevice’s Chris Newmarker also returns with his Newmarker’s Newsmakers including - Dr. Mehmet Oz, CMS, Supira, GE Healthcare and Medtronic.
This episode is sponsored by DeviceTalks Boston.
Thank you for listening to this episode of the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. -
In this episode of Structural Heart Talks, Larry Wood, Corporate VP and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart at Edwards Lifesciences, discusses the transformative journey of transcatheter aortic valve replacement (TAVR) and the SAPIEN valve. Wood reflects on the innovation that enables minimally invasive heart valve replacement, which has become the standard of care for severe aortic stenosis and offers patients faster recovery and greater independence.
The conversation explores Edwards’ efforts to expand access to TAVR, emphasizing the importance of reducing undertreatment and addressing outdated clinical guidelines that delay intervention. Wood also highlights findings from the recent EARLY TAVR study, which challenges long-standing paradigms and advocates for changes to the guidelines to allow earlier treatment of aortic stenosis before symptoms appear.
Tune in to the 2021 episode of DeviceTalks Weekly where Host, Tom Salemi visits with Larry Wood to discuss the "Complete History of the SAPIEN TAVR," here: https://www.devicetalks.com/the-complete-history-of-the-sapien-tavr-from-pvts-emerging-idea-to-edwards-lifesciences-success/
Thank you to Confluent Medical Technologies for sponsoring this episode of Structural Heart Talks. To learn more about how Confluent Medical supports medical device companies, visit: www.confluentmedical.com.
Thank you for listening to the Structural Heart Talks podcast. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks or the Structural Heart Talks on YouTube Podcasts to ensure you never miss an episode. -
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Marwan Berrada, founder and managing partner of Santa Clara-based T45 Labs about how incubators can start new companies at a time when early-stage funding is scarce.
MassDevice Editor Chris Newmarker deliveres his Newmarker’s Newsmakers including GE HealthCare, Zimmer Biomet, Momentis Surgical, Johnson & Johnson MedTech and, of course, the news surrounding HHS.
This episode is sponsored by DeviceTalks Boston. Register at Boston.DeviceTalks.com.
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. -
In this StrykerTalks episode, Andy Pierce, Group President of MedSurg and Neurotechnology at Stryker, shares his insights on the company’s commitment to innovation, growth, and patient-centered care.
Pierce reflects on his 29-year journey with Stryker, highlighting the high-performance culture shaped by entrepreneurial spirit, growth targets, and strategic acquisitions. He discusses how Stryker’s decentralized structure supports quick, localized decision-making while fostering collaboration across its business units.
The conversation also explores the company's M&A strategy, focusing on acquisitions that bring de-risked, high-impact technologies that align with Stryker’s long-term goals. Pierce provides an inside look at Stryker's engagement with the soft tissue robotics space, its approach to balancing internal and external innovation, and the proactive steps Stryker takes to address healthcare staffing shortages with technology.
Thank you to Vantedge Medical for sponsoring this episode. To learn more about how Vantedge Medical works with medical device companies, visit www.vantedgemedical.com
Thank you for listening to the StrykerTalks Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. -
In this week’s DeviceTalks Weekly Podcast, Host Tom Salemi interviews Dr. Andrew Napier, a former army medic and ER doc who saw a need for sh*t that works, specifically an intubation tool that allowed for easier access to the airway. He developed his own device and started a company, IntuBlade, to make his vision a reality. Thank you to Dr. Napier and all listeners who have served in the military. Happy Veterans Day.
MassDevice Editor Chris Newmarker brings his Newmarker’s Newsmakers – Philips, Precision Neuroscience, Integra Lifesciences, Boston Scientific, and Johnson & Johnson.
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe now to the DeviceTalks Podcast Network. -
In this episode of Neuro Innovation Talks, Head of Global Strategic Marketing and Strategic Relationships at Johnson & Johnson MedTech Neurovascular, John Murray, returns to the DeviceTalks podcast studio to spotlight one of the foremost pioneers in neurointervention, Fernando Vinuela, MD, Professor Emeritus of UCLA Interventional Neuroradiology. Dr. Vinuela shares his journey through the groundbreaking evolution of neurovascular treatments and the collaborative spirit that propelled early advancements in stroke care.
From his foundational work on detachable coils to his transformative mentorship, Dr. Vinuela reflects on his contributions to neurointervention and the significant milestones that have shaped the field. He also provides insights into his impactful work in Brazil, where he has helped establish stroke treatment programs, expanding the reach of life-saving neurovascular care.
Thank you to Confluent Medical Technologies for sponsoring this episode of Neuro Innovation Talks. To learn more about how Confluent Medical supports medical device companies, visit: https://confluentmedical.com.
Special thanks to the following for their support in the development of this podcast: Joanna Colangelo, Mark Dickinson, Whitney Garrett, Tracy Murray, SYK, Dr. Vinuela, Dr. Satoshi Tateshima, Dr. Dileep Yavagal.
Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode.
Thank you for supporting the Neuro Innovation Talks podcast! -
In this episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker tackle some of the weeks’ biggest news including the FDA giving a nod to Distalmotion’s Dexter robot and the Yankees blowing the World Series.
Distalmotion CEO Greg Roche visits to share his thoughts on both. Then Tom interviews Chad Hoskins, CEO of Phagenesis, a startup developing a neurostimulation device that could help stroke survivors recover.
This week’s Newmaker’s Newsmakers include Medtronic, Masimo, Exactech, Solventum and you already know about this week’s number one.
This episode is sponsored by DeviceTalks Boston. Register now at Boston.DeviceTalks.com.
Thanks for listening to this episode of the DeviceTalks Weekly Podcast.
Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode. -
In this episode of IntuitiveTalks, Dirk Barten, Senior VP and GM of EU Commercial and Marketing at Intuitive, takes us through Europe's unique surgical robotics landscape. He discusses the differences in adoption rates between the US and Europe, where surgical robotics uptake has lagged by about five to seven years.
Barten also explains the critical role Intuitive’s digital ecosystem plays in supporting surgeons and healthcare teams throughout Europe. Through tools like tele-education and digital hubs, Intuitive is providing accessible training and data support, which he believes are essential in driving improved patient outcomes and meeting hospitals' needs for more integrated and efficient surgical solutions.
In addition, Barten explores how healthcare system consolidation in major European countries is reshaping hospital networks, leading to increased centralization of complex procedures. He highlights Intuitive’s investment in expanding its infrastructure across Europe, with new sites in Switzerland, Germany, and the UK, underscoring Intuitive’s confidence in the region’s growth potential despite ongoing economic pressures.
Thank you to Kollmorgen for sponsoring this episode. To learn more about how Kollmorgen works with medical device companies, please visit: www.kollmorgen.com.
And that’s not all! Explore some of Kollmorgen’s success stories below:
1. Kollmorgen and Stereotaxis Advance the Precision and Safety of Surgical Robots | https://www.kollmorgen.com/en-us/case-studies/kollmorgen-and-stereotaxis-advance-precision-and-safety-surgical-robots
2. Enabling New Surgical Possibilities with High-Torque, Low-Temperature and Compact-Size Motors | https://www.kollmorgen.com/en-us/case-studies/enabling-new-surgical-possibilities-high-torque-low-temperature-and-compact-size
Thank you for listening to the IntuitiveTalks Podcast.
Subscribe to the DeviceTalks Podcast Network on every major podcast platform. -
In this episode of DeviceTalks AI, Host Kayleen Brown sits down with Medtronic’s VP & Global Chief AI Officer, Rodolphe Katra, PhD, MBA, discusses the pivotal role of AI in advancing MedTech and how Medtronic is responding.
Dr. Katra walks us through Medtronic’s AccuRhythm AI, which enhances cardiac monitoring by improving arrhythmia detection and reducing false positives through cloud-based algorithms.
He also explores how AI is being integrated into Medtronic’s surgical robotics platforms to boost precision and enable personalized care.
Additionally, Dr. Katra highlights Medtronic’s AI Compass, a set of ethical guidelines ensuring AI is used securely, without bias, and in a way that improves patient outcomes. Lastly, Katra offers key insights into how Medtronic is using AI to innovate both cardiac care and surgical robotics while maintaining a strong commitment to ethical AI practices.
This conversation comes to you courtesy of our episode sponsor, AcuityMD. To learn more about AcuityMD, visit www.acuitymd.com.
Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode.
Thank you for listening to DeviceTalks AI! -
In this episode of AbbottTalks, Sandra Lesenfants, SVP of Abbott’s structural heart business, discusses the latest advancements in structural heart care, focusing on Abbott's transformative TriClip device for tricuspid regurgitation.
Lesenfants highlights Abbott’s commitment to patient-centered innovation, emphasizing the importance of creating solutions that meet patients’ needs through safe and effective technologies. She also shares Abbott’s approach to expanding access to minimally invasive therapies, particularly in underserved populations worldwide, and the role of physician partnerships in advancing structural heart interventions.
Lastly, Lesenfants underscores the company’s efforts to increase diversity in clinical trials, noting the importance of intentional inclusivity across gender and ethnicity to better serve diverse patient populations.
Thank you to Confluent Medical Technologies for sponsoring this episode of AbbottTalks. For more information on how Confluent Medical works with medical device companies, visit https://confluentmedical.com/.
Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode. -
In this episode of the DeviceTalks Weekly Podcast, the DeviceTalks team wraps up the two amazing days of insights and networking at DeviceTalks West.
Tom Salemi, Kayleen Brown and Chris Newmarker welcome guests Alexis Moores, Senior Account Manager, and Steven Thill, Senior Director of Infor, which announced a partnership with NVIDIA at DeviceTalks West, the culmination of a connection forged at DeviceTalks Boston!
Thank you to Infor for sponsoring this episode of DeviceTalks Weekly. To learn how Infor supports MedTech companies visit www.infor.com.
The panel covers a few of the highlights from the event discussion surgical robotics, AI, interventional tools, women’s health.
But first, we unpack the details of PUMPKINGATE!
Thanks for listening to this episode of the DeviceTalks Weekly Podcast. -
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi opens by making a strong case for MedTech people to attend DeviceTalks West, which is happening on Oct. 16-17.
Go to West.DeviceTalks.com to register.
MassDevice Editor Chris Newmarker brings his Newmarker’s Newsmakers – Women’s Health, Philiips, Nyxoah, CMR Surgical, and Johnson & Johnson MedTech.
Finally, Paul Grand, CEO of MedTech Innovator, introduces DeviceTalks listeners to the five finalists who will compete for the 2024 Early-Stage Grand Prize. The winner will be voted for at the AdvaMed annual meeting in Toronto.
Thank you for listening to the DeviceTalks Weekly Podcast
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. -
In this week’s episode of the DeviceTalks Weekly Podcast, Nick Damiano, co-founder and CEO of Andromeda Surgical, previews his talk at DeviceTalks West by introducing listeners to the potential of autonomous surgery. Still early goings on, but Damiano paints and interesting picture of the future.
If you want to see the future register at West.DeviceTalks.com.
Speaking of the future, Host Tom Salemi speaks with Brody Galloway, a young MedTech professional who has turned his life’s healthcare experiences into a love of the industry and a drive to help.
Anyone who wants to help should go to EnvisionMedtech.org.
MassDevice Editor Chris Newmarker returns with his Newmarker’s Newsmakers – Surgical Robotics, Medtronic, ResMed, Layoffs and, of course, Baxter Healthcare.
Thanks for listening to the DeviceTalks Podcast Network.
Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode of this or other industry-leading podcasts. -
In this episode of Neuro Innovation Talks, the newest podcast series in the DeviceTalks Podcast Network, the DeviceTalks editors invite Johnson & Johnson MedTech Neurovascular's Head of Global Marketing, John Murray to take over the podcast studio and bring to light the stories from the pioneering neurointerventionalists who have helped shape the stroke industry.
In the first episode, Host John Murray sits down with Alejandro Berenstein, MD, Professor of Neurosurgery, Pediatrics and Radiology, Director of pediatric Cerebrovascular Surgery, Mount Sinai Health System, to discuss the incredible evolution of neurovascular surgery and its impact on modern healthcare. Dr. Berenstein shares his early inspirations, key breakthroughs, and the significant role mentors played in shaping his illustrious career. Highlighting landmark projects like the pioneering treatments for Vein of Galen Malformations (VOGM) and facial vascular anomalies, Dr. Berenstein shares the complexities and triumphs of his work. His story provides a blueprint for aspiring medical professionals and innovators, demonstrating how personal experiences, visionary thinking, and collaborative efforts can lead to groundbreaking advancements that significantly impact patient outcomes.
Thank you to Zeus for sponsoring this episode of Neuro Innovation Talks. To learn more about how Zeus supports medical device companies, visit: www.zeusinc.com.
Special thanks to the following for their support in the development of this podcast: Joanna Colangelo, Johanna Fifi, Whitney Garrett, Howard Riina, Lillian Medina, and J. Mocco.
Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode.
Thank you for supporting the Neuro Innovation Talks podcast! - もっと表示する
